Evidence map›Paper›PMID 25056980›Full record

ArticleBMJ open2014

Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD).

Jennifer K Quint, Hana Müllerova, Rachael L DiSantostefano, Harriet Forbes, Susan Eaton, John R Hurst, Kourtney Davis, Liam Smeeth

Registry-linked trialOpen access · goldAbstract readValidation Study
In one paragraph

Article in BMJ open, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02681848 (What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?), which is not on this map. Cited by 160 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
160citing papers in PubMed, 4 pooled it
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02681848 unknown statusnot on this map

What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?

TypeobservationalSponsorUniversity of BristolRan2006 to 2019Enrolled180,000ConditionsSmoking Cessation, Cardiovascular Disease, Respiratory Disease, Myocardial InfarctionArmsVarenicline, Nicotine replacement therapy
3 · Its place in the literature

Who cites it

160 citing papers in PubMed, 4 syntheses or guidelines pooled it, 253 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

100 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Jennifer K QuintDepartment of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Hana MüllerovaDepartment of Respiratory Epidemiology, GlaxoSmithKline R&D, Uxbridge, UK.
Rachael L DiSantostefanoDepartment of Respiratory Epidemiology, GlaxoSmithKline R&D, ResearchTriangle Park, North Carolina, USA.
Harriet ForbesDepartment of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Susan EatonClinical Practice Research Datalink Group, Medicines and Healthcare Products Regulatory Agency, London, UK.
John R HurstDepartment of UCL Respiratory Medicine, Royal Free Campus, University College London Medical School, London, UK.
Kourtney DavisDepartment of Respiratory Epidemiology, GlaxoSmithKline R&D, Uxbridge, UK.
Liam SmeethDepartment of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
London School of Hygiene & Tropical Medicine · GBGlaxoSmithKline (United Kingdom) · GBClinical Practice Research Datalink · GBResearch Triangle Park Foundation · USUniversity College London · GB

Funding

Medical Research Council G0902135Medical Research Council MR/K006584/1Wellcome Trust 098504
6 · The paper itself

Abstract

objectivesThe optimal method of identifying people with chronic obstructive pulmonary disease (COPD) from electronic primary care records is not known. We assessed the accuracy of different approaches using the Clinical Practice Research Datalink, a UK electronic health record database.

setting951 participants registered with a CPRD practice in the UK between 1 January 2004 and 31 December 2012. Individuals were selected for ≥1 of 8 algorithms to identify people with COPD. General practitioners were sent a brief questionnaire and additional evidence to support a COPD diagnosis was requested. All information received was reviewed independently by two respiratory physicians whose opinion was taken as the gold standard. PRIMARY OUTCOME MEASURE: The primary measure of accuracy was the positive predictive value (PPV), the proportion of people identified by each algorithm for whom COPD was confirmed.

results951 questionnaires were sent and 738 (78%) returned. After quality control, 696 (73.2%) patients were included in the final analysis. All four algorithms including a specific COPD diagnostic code performed well. Using a diagnostic code alone, the PPV was 86.5% (77.5-92.3%) while requiring a diagnosis plus spirometry plus specific medication; the PPV was slightly higher at 89.4% (80.7-94.5%) but reduced case numbers by 10%. Algorithms without specific diagnostic codes had low PPVs (range 12.2-44.4%).

conclusionsPatients with COPD can be accurately identified from UK primary care records using specific diagnostic codes. Requiring spirometry or COPD medications only marginally improved accuracy. The high accuracy applies since the introduction of an incentivised disease register for COPD as part of Quality and Outcomes Framework in 2004.

Indexed as

Databases, FactualElectronic Health RecordsPulmonary Disease, Chronic ObstructiveAgedAlgorithmsBiomedical ResearchFemaleHumansMaleMiddle AgedPrimary Health CareRESPIRATORY MEDICINE (see Thoracic Medicine)THORACIC MEDICINE

Identifiers

PMID25056980
PMCPMC4120321
OpenAlexW2172005465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.